Stephens Consulting, LLC Astrazeneca PLC Transaction History
Stephens Consulting, LLC
- $292 Billion
- Q3 2025
A detailed history of Stephens Consulting, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Stephens Consulting, LLC holds 659 shares of AZN stock, worth $55,243. This represents 0.02% of its overall portfolio holdings.
Number of Shares
659
Previous 1,122
41.27%
Holding current value
$55,243
Previous $78.4 Million
35.52%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
498MCall Options Held
7.11MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.35 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.45 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.63 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.61 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $260B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...